Results Snapshot
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2024 is -3.91% vs 4.66% in Dec 2023
Standalone Net Profit
YoY Growth in nine months ended Dec 2024 is 2,922.22% vs 0.00% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2024 is 14,700.00% vs -116.67% in Dec 2023
Interest
YoY Growth in nine months ended Dec 2024 is -12.00% vs 0.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
Compare Nine Monthly Results Of Genpharmasec With
Nine Monthly - Net Sales
YoY Growth in nine months ended Dec 2024 is -3.91% vs 4.66% in Dec 2023
Nine Monthly - Standalone Net Profit
YoY Growth in nine months ended Dec 2024 is 2,922.22% vs 0.00% in Dec 2023
Nine Monthly - Operating Profit (PBDIT)
YoY Growth in nine months ended Dec 2024 is 14,700.00% vs -116.67% in Dec 2023
Nine Monthly - Interest
YoY Growth in nine months ended Dec 2024 is -12.00% vs 0.00% in Dec 2023
Nine Monthly - Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023